{"id":"https://openalex.org/W2049547244","doi":"https://doi.org/10.2174/1568009053765780","title":"EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics","display_name":"EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics","publication_year":2005,"publication_date":"2005-04-30","ids":{"openalex":"https://openalex.org/W2049547244","doi":"https://doi.org/10.2174/1568009053765780","mag":"2049547244","pmid":"https://pubmed.ncbi.nlm.nih.gov/15892616"},"language":"en","primary_location":{"id":"doi:10.2174/1568009053765780","doi":"https://doi.org/10.2174/1568009053765780","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568009053765780","pdf_url":null,"source":{"id":"https://openalex.org/S26162253","display_name":"Current Cancer Drug Targets","issn_l":"1568-0096","issn":["1568-0096","1873-5576"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Cancer Drug Targets","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000084691","display_name":"Rene\u00e9 C. Ireton","orcid":"https://orcid.org/0000-0002-5844-9981","observed_orcids":["https://orcid.org/0000-0002-5844-9981"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Ireton","raw_affiliation_strings":["Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt Univesrity School of Medicine, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt Univesrity School of Medicine, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020742692","display_name":"Jin Chen","orcid":"https://orcid.org/0000-0002-5557-2079","observed_orcids":["https://orcid.org/0000-0002-5557-2079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1776,"has_fulltext":false,"cited_by_count":178,"citation_normalized_percentile":{"value":0.86821545,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"5","issue":"3","first_page":"149","last_page":"157"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12061","display_name":"Axon Guidance and Neuronal Signaling","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12061","display_name":"Axon Guidance and Neuronal Signaling","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epha2","display_name":"EphA2","score":0.9829999804496765},{"id":"https://openalex.org/keywords/eph-receptors","display_name":"Eph receptors","score":0.7379999756813049},{"id":"https://openalex.org/keywords/ephrins","display_name":"ephrins","score":0.9039999842643738},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.7440000176429749},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7870000004768372},{"id":"https://openalex.org/keywords/tumor-stroma","display_name":"tumor stroma","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.7829999923706055},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.46399998664855957},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7639999985694885},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C19331615","wikidata":"https://www.wikidata.org/wiki/Q423602","display_name":"Erythropoietin-producing hepatocellular (Eph) receptor","level":4,"score":0.9358969926834106},{"id":"https://openalex.org/C150582083","wikidata":"https://www.wikidata.org/wiki/Q18250395","display_name":"EPH receptor A2","level":4,"score":0.9336392879486084},{"id":"https://openalex.org/C170286479","wikidata":"https://www.wikidata.org/wiki/Q24787399","display_name":"Ephrin","level":3,"score":0.8595837950706482},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.7364826202392578},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7015737295150757},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5513095259666443},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5452211499214172},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.5111754536628723},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4823600649833679},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4472799301147461},{"id":"https://openalex.org/C2911166042","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor Protein-Tyrosine Kinases","level":4,"score":0.43859779834747314},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.43450745940208435},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3602859377861023},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3484160602092743},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.11598700284957886},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06497251987457275},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06392437219619751}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D036104","descriptor_name":"Receptor, EphA2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D036104","descriptor_name":"Receptor, EphA2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1568009053765780","doi":"https://doi.org/10.2174/1568009053765780","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568009053765780","pdf_url":null,"source":{"id":"https://openalex.org/S26162253","display_name":"Current Cancer Drug Targets","issn_l":"1568-0096","issn":["1568-0096","1873-5576"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Cancer Drug Targets","raw_type":"journal-article"},{"id":"pmid:15892616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15892616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current cancer drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G723262780","display_name":"Endothelial mTOR signaling in tumor-blood vessel interaction","funder_award_id":"R01CA095004","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140120206","https://openalex.org/W2152055261","https://openalex.org/W3077428160","https://openalex.org/W7166696499","https://openalex.org/W3091130879","https://openalex.org/W4392099058","https://openalex.org/W2359328868","https://openalex.org/W3019681744","https://openalex.org/W2033222419","https://openalex.org/W2033124377"],"abstract_inverted_index":{"Eph":[0,26,75],"receptors":[1,76,98],"are":[2,33,99],"a":[3,38],"unique":[4],"family":[5,49],"of":[6,40,114,124,143],"receptor":[7],"tyrosine":[8],"kinases":[9],"(RTK)":[10],"that":[11,64,74],"play":[12],"critical":[13],"roles":[14,123],"in":[15,37,54,68,81,85,126,146],"embryonic":[16],"patterning,":[17],"neuronal":[18],"targeting,":[19],"and":[20,28,42,58,84,93,139],"vascular":[21],"development":[22],"during":[23],"normal":[24],"embryogenesis.":[25],"RTKs":[27],"their":[29],"ligands,":[30],"the":[31,86,90,121,129,140],"ephrins,":[32],"also":[34],"frequently":[35],"overexpressed":[36,53],"variety":[39],"cancers":[41],"tumor":[43,69,82,87,91,94,115],"cell":[44],"lines.":[45],"In":[46],"particular,":[47],"one":[48],"member,":[50],"EphA2,":[51],"is":[52],"breast,":[55],"prostate,":[56],"lung,":[57],"colon":[59],"cancers.":[60],"Unlike":[61],"traditional":[62],"oncogenes":[63],"often":[65],"function":[66],"only":[67],"cells,":[70],"recent":[71],"data":[72],"show":[73],"mediate":[77],"cell-cell":[78],"interactions":[79],"both":[80],"cells":[83],"microenvironment,":[88],"namely":[89],"stroma":[92],"vasculature.":[95],"Thus,":[96],"EphA2":[97,125,133,144],"attractive":[100],"targets":[101],"for":[102],"drug":[103],"design,":[104],"as":[105],"targeting":[106],"these":[107],"molecules":[108],"could":[109],"simultaneously":[110],"inhibit":[111],"several":[112],"aspects":[113],"progression.":[116],"This":[117],"review":[118],"focuses":[119],"on":[120],"multiple":[122],"cancer":[127,148],"progression,":[128,138],"mechanisms":[130],"by":[131],"which":[132],"inhibition":[134,145],"may":[135],"halt":[136],"this":[137],"pre-clinical":[141],"results":[142],"various":[147],"model":[149],"systems.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}